German China India

France: Life Sciences

Novasep Invests 4 Million Euros to Expand Cryogenic Production Capacity

| Editor: Alexander Stark

The investment includes the installation of a new c-GMP cryogenic production line, capable of operating at temperatures as low as -80°C.
The investment includes the installation of a new c-GMP cryogenic production line, capable of operating at temperatures as low as -80°C. (Source: Novasep)

Novasep announced a € 4 million investment to expand c-GMP capacity for clinical and commercial supply of APIs at its Chasse-sur-Rhône facility in France.

Lyon/France — The investment includes the installation of a new c-GMP cryogenic production line, capable of operating at temperatures as low as -80 °C. It is equipped with a 4 m3 Hastelloy reactor, filter drier and clean room.

The investment also includes an expansion of the c-GMP pilot-plant capabilities with the addition of a new stream comprising a 400 L Hastelloy reactor, filter drier and clean room. According to the company, this will add flexible small-scale manufacturing capacity and reinforce the site’s capability to handle both clinical development needs and low volume APIs.

The investment will be operational by the beginning of 2018. The company’s total low temperature capacity will then reach more than 35 m3.

“By increasing cryogenics capacity at the current Chasse-sur-Rhône facility, we strengthen Novasep’s small and large-scale volume offering for low temperature manufacturing,” Jean-Pierre Pilleux, General Manager of the Chasse-sur-Rhône site said, adding that it would give the manufacturer more flexibility and allow them to address the increasing market demand for these types of capabilities.

First Sorbitol Plant Project in Vietnam

Sorbitol Project

First Sorbitol Plant Project in Vietnam

07/21/2014 - Novasep-MIE consortium to construct the first sorbitol production plant in Vietnam, which would enable the country to domestically produce sorbitol, a sugar substitute it currently imports. read...

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 44976935 / Pharma & Food)